Multiple Ascending Dose Study of PCSK-9 Inhibitor (IBI306) in Chinese Patients With Hypercholesterolemia
Clinical trial NCT03815812 · COMPLETED
Trial details
- NCT number
- NCT03815812
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-07
- Primary completion
- 2019-12-25
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.